Cartesian Therapeutics, Inc.·4

Mar 13, 4:14 PM ET

Singer Michael 4

Research Summary

AI-generated summary

Updated

Cartesian Therapeutics (RNAC) Director Michael Singer Gifts 6,555 Shares

What Happened Michael Singer, a director of Cartesian Therapeutics, reported a disposition by gift (transaction code G) of 6,555 shares on March 13, 2026. The filing shows $0.00 consideration (i.e., the shares were transferred as a gift), so the reported transaction value is $0.

Key Details

  • Transaction date: 2026-03-13
  • Transaction type/code: Gift (G)
  • Shares disposed: 6,555
  • Price/consideration: $0.00 (gift)
  • Shares owned after transaction: not specified in the information provided
  • Filing date / period of report: 2026-03-13 (appears timely; no late-filing flag indicated)
  • Footnotes in the filing (F1–F6) indicate various holdings are in trusts and custodial accounts for the reporting person’s spouse and children and that the reporting person or spouse may serve as trustee or custodian

Context Gifts are common insider transactions used for estate or family transfers and do not necessarily signal a buy/sell view on the stock. Because no cash changed hands, the transaction does not reflect a market-based sale price; retail investors should treat this as a transfer of ownership rather than a vote on company prospects.